In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment - STAT

In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment - STAT
Business

Listen to this article

0%

The Food and Drug Administration has rejected a radiopharmaceutical therapy because of manufacturing issues, halting what would have been a competitor for Novartis.Β  The drug, ITM-11, had been devel… [+946 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected